£7.5M
The Scottish National Investment Bank led the Series A round to accelerate clinical validation and regulatory submission of the company's respiratory monitoring platform.
PneumoWave develops a wearable biosensor platform for remote respiratory monitoring.
PneumoWave develops wearable biosensor technology designed to remotely diagnose and monitor potentially fatal respiratory changes. The digital health business focuses on preventing deaths and reducing hospital admissions.
Cash at bank
Net current assets
Total assets less current liabilities
Shareholders' funds
Fixed assets
Current assets
Cash, assets and headcount from PneumoWave's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Bruce Henderson
CEO
The Scottish National Investment Bank led the Series A round to accelerate clinical validation and regulatory submission of the company's respiratory monitoring platform.